BENEGAST CONTALAX, created in 2014 (Belgium), from 303 sister brands and 4958 competing brands. The BENEGAST CONTALAX brand is owned by Perrigo, a company listed in New York. The ISIN, the company's International Securities Identification Number, is IE00BGH1M568. The sector of BENEGAST CONTALAX is Drug Manufacturers.
Investment simulator :
Portfolio valuation
Perrigo
(BENEGAST CONTALAX)
over 5 years*
USD 19.26